Celularity
CELU
73 hedge funds and large institutions have $44.2M invested in Celularity in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 16 closing their positions.
2,568% more call options, than puts
Call options by funds: $1.07M | Put options by funds: $40K
67% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 15
1% more funds holding
Funds holding: 72 → 73 (+1)
1% less ownership
Funds ownership: 24.64% → 23.64% (-1%)
6% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 16
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
34% less capital inflows, than outflows
Capital inflows: $1.91M | Capital outflows: $2.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$375K |
| 2 |
BlackRock
New York
|
+$254K |
| 3 |
D.E. Shaw & Co
New York
|
+$140K |
| 4 |
Biltmore Family Office
Charlotte,
North Carolina
|
+$106K |
| 5 |
Swiss National Bank
Zurich,
Switzerland
|
+$102K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B. Riley Financial
Los Angeles,
California
|
-$870K |
| 2 |
Millennium Management
New York
|
-$433K |
| 3 |
Vident Investment Advisory
Alpharetta,
Georgia
|
-$345K |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$127K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$79K |
CELU Hedge Fund Activity: Q4 2022 in Review
73 of the 6,238 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q4 2022, worth a combined $44.2M — down 45% from $81M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of CELU and 15 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 25 added.
The largest buyer was State Street, adding an estimated $375K. The largest seller was B. Riley Financial, exiting entirely with an estimated $870K sold.
- 73 institutional investors held Celularity (CELU) as of Q4 2022, up from 72 in Q3 2022.
- Funds reported $44.2M of Celularity stock for Q4 2022, down 45% quarter-over-quarter.
- 15 funds opened new Celularity positions in Q4 2022 and 16 closed out, a net change of -1 holder.
- The largest Celularity buyer in Q4 2022 was State Street, an estimated $375K added.
- The largest Celularity seller in Q4 2022 was B. Riley Financial, an estimated $870K sold.
Based on aggregated 13F filings for Q4 2022.